Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

被引：13

作者：

Venook, Alan P.

Blanke, Charles D.

Niedzwiecki, Donna

Lenz, Heinz-Josef

Taylor, John R.

Hollis, Donna R.

Sutherland, Susan

Goldberg, Richard M.

机构：

[1] Univ Calif San Francisco, Dept Clin Med, San Francisco, CA 94115 USA

[2] Canc & Leukemia Grp B, Chicago, IL USA

[3] SW Oncol Grp, San Antonio, TX USA

[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[5] Duke Univ, Durham, NC USA

[6] Univ So Calif, Los Angeles, CA USA

[7] Univ N Carolina, Chapel Hill, NC USA

来源：

CLINICAL COLORECTAL CANCER | 2007年 / 6卷 / 07期

关键词：

bevacizumab; cetuximab; FOLFIRI; FOLFOX;

D O I：

10.3816/CCC.2007.n.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：536 / 538

页数：3

共 50 条

[21] PHASE-II TRIAL OF AMONAFIDE IN ADVANCED PANCREAS CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
LEICHMAN, CG
TANGEN, C
MACDONALD, JS
LEIMERT, T
FLEMING, TR
INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 219 - 221
[22] METHYL-GAG IN ADVANCED COLON CANCER - A PHASE-II TRIAL OF THE SOUTHWEST ONCOLOGY GROUP
KNIGHT, WA
LOESCH, DM
LEICHMAN, LP
FABIAN, C
OBRYAN, RM
CANCER TREATMENT REPORTS, 1982, 66 (12): : 2099 - 2100
[23] Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
Clamon, G
Herndon, J
Cooper, R
Chang, AY
Rosenman, J
Green, MR
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 4 - 11
[24] Developmental chemotherapy in advanced ovarian cancer: Incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182)
Bookman, MA
SEMINARS IN ONCOLOGY, 2002, 29 (01) : 20 - 31
[25] A comparative analysis of quality of life data from a Southwest Oncology Group randomized trial of advanced colorectal cancer
Troxel, AB
STATISTICS IN MEDICINE, 1998, 17 (5-7) : 767 - 779
[26] PHASE-II TRIAL OF BISANTRENE IN PATIENTS WITH ADVANCED SARCOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
COWAN, JD
GEHAN, E
RIVKIN, SE
JONES, SE
CANCER TREATMENT REPORTS, 1986, 70 (05): : 685 - 686
[27] CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN ADVANCED COLORECTAL CANCER: A PHASE III TRIAL
Stathopoulos, G. P.
Batziou, C.
Trafalis, D.
Koutantos, J.
Batzios, S.
Stathopoulos, J.
Legakis, J.
Armacolas, A.
ANNALS OF ONCOLOGY, 2010, 21 : 196 - 196
[28] A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study
Higano, CS
Crowley, JJ
Veith, RV
Livingston, RB
INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) : 153 - 156
[29] A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a southwest oncology group study
Celestia S. Higano
John J. Crowley
Robert V. Veith
Robert B. Livingston
Investigational New Drugs, 1997, 15 : 153 - 156
[30] PHASE-II TRIAL OF DIAZIQUONE IN ADVANCED LARGE BOWEL CARCINOMA IN PREVIOUSLY TREATED AND UNTREATED PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
SHILDT, R
STEPHENS, RL
SUBRAMANIAN, VP
BAKER, LH
FLETCHER, WS
OBRYAN, RM
MCCRACKEN, JD
CANCER TREATMENT REPORTS, 1985, 69 (06): : 709 - 710

← 1 2 3 4 5 →